Events

Avis De Sécurité sur Stryker Neurovascular Target Detachable Coils

Selon Health Sciences Authority (HSA), ce/cet/cette avis de sécurité concerne un dispositif en/au/aux/à Singapore qui a été fabriqué par Stryker Singapore Pte Ltd.

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Field Safety Notice
  • ID de l'événement
    600:41/01-014/16/03_45
  • Date
    2016-06-17
  • Pays de l'événement
    Singapore
  • Source de l'événement
    HSA
  • URL de la source de l'événement
    https://www.hsa.gov.sg/announcements
  • Notes / Alertes
    Data from Singapore is current through September 2018. All of the data comes from the Health Sciences Authority (HSA), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Singapore.
  • Notes supplémentaires dans les données
    Stryker Neurovascular

Device

Stryker Neurovascular Target Detachable Coils
  • Modèle / numéro de série
  • Description du dispositif
    Stryker Neurovascular Target Detachable Coils, Stryker Neurovascular
  • Manufacturer
    Stryker Singapore Pte Ltd

Manufacturer

Stryker Singapore Pte Ltd
  • Société-mère du fabricant (2017)
    Boston Scientific
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    HSAHSA